Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Allopurinol/febuxostat

Ventricular tachycardia and lack of efficacy: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zhu Y, et al. Febuxostat Increases Ventricular Arrhythmogenesis Through Calcium Handling Dysregulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicological Sciences 189: 216-224, No. 2, Oct 2022. Available from: URL: http://doi.org/10.1093/toxsci/kfac073 Zhu Y, et al. Febuxostat Increases Ventricular Arrhythmogenesis Through Calcium Handling Dysregulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicological Sciences 189: 216-224, No. 2, Oct 2022. Available from: URL: http://​doi.​org/​10.​1093/​toxsci/​kfac073
Metadaten
Titel
Allopurinol/febuxostat
Ventricular tachycardia and lack of efficacy: 2 case reports
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33553-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Nivolumab

Case report

Tadalafil

Case report

Multiple drugs

Case report

Rosuvastatin